Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

Fig. 6

Histograms show the levels of several inflammatory biomarkers in CSF, plasma and pEVs samples of EOMCI Aβ ( +)/(-) patients. Statistical analysis was performed with an unpaired t test with Welch's correction. p < 0.05 (*). IL12B pEVs: p = 0.0465; CI (95%) = 0.0051 to 0.6309/IL12B CSF: p = 0.005; CI (95%) = 0.2104 to 0.6800/CXCL11 pEVs: p = 0.0201; CI (95%) = 0.1278 to 1.406/CXCL11 CSF: p = 0.0371; CI (95%) = 0.0287 to 0.8745/CXCL5 pEVs: p = 0.0486; CI (95%) = 0.0030 to 0,9610/CX3CL1 pEVs: p = 0.0369; CI (95%) = 0.0257 to 0.7659

Back to article page